SP INDUSTRIES acquired by ATS CORPORATION
Context
ATS Automation has finalized the acquisition of SP Industries from Harbour Group, a maneuver designed to fundamentally expand the group's capabilities in the pharmaceutical and life sciences sectors. The strategic rationale for this transaction centers on a "portfolio-expansion" play, merging the target's industry-leading aseptic and non-aseptic lyophilization technology with the group’s established global leadership in automated manufacturing solutions. This fusion effectively creates a specialized powerhouse in the bioprocessing equipment arena, providing the organization with the high-precision hardware required to address the increasing complexity of drug development and fill-finish operations.
SP INDUSTRIES, which reported an EBITDA margin of [members only] in 2021, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Industry & Manufacturing sector (11.7x).
-> Deep-dive in Industry & Manufacturing market trends
Target
SP Industries operates as a premier technology organization dedicated to the design and manufacture of high-grade biopharmaceutical processing equipment and laboratory apparatus. The entity’s business model is centered on a proprietary framework of lyophilization and aseptic fill-finish solutions, which are mission-critical for the stabilization and packaging of temperature-sensitive biologics and vaccines. Its value proposition is anchored in technical operational depth, providing a comprehensive portfolio that spans from research-scale freeze dryers to large-capacity commercial production systems. Strategically, the firm focuses on the entire pharmaceutical drug development lifecycle, leveraging a strong recurring revenue stream through its specialized labware and glassware business. By maintaining a specialized focus on standardized, repeatable results in sterile environments, the organization ensures a vital role in the structural efficiency of pharmaceutical manufacturing. The entity prioritizes technical innovation and industrialized quality standards to facilitate the structural advancement of therapeutic production worldwide.
Ent. Value
$300–700M
Equity Value
[members only]
Multiples
EV / Revenue
1x–3x
EV / EBITDA
15x–25x
EV / EBIT
[members only]
Historical Financials (USD)
Similar deals in Industrial Equipment
Similar deals in Industrial Equipment
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 01/2022 | ENDEAVOUR | METALMECCANICA SPAGGIARI | ITALY | Lifting & Handling |
| 01/2022 | EDDYFI TECHNOLOGIES | ZETEC | UNITED STATES | Instrumentation & Measurement |
| 11/2021 | PARTNERS GROUP | DIVERSITECH | UNITED STATES | Valves, Pumps & Taps |
| 08/2021 | NORDSON CORPORATION | NDC TECHNOLOGIES | UNITED STATES | Instrumentation & Measurement |
| 07/2021 | LT CAPITAL | ROLLAKIN (BOLLIN / ROLLIN) | FRANCE | Components |
| 07/2021 | CAPZA | NOVARC | FRANCE | Components |
| 07/2021 | MAREL | VALKA | ICELAND | Food & Beverage Lines |
| 06/2021 | XEBEC | TIGER FILTRATION | UNITED KINGDOM | Valves, Pumps & Taps |
| 06/2021 | EQUINOX | MIGAL GROUP | ITALY | Valves, Pumps & Taps |
| 04/2021 | HITACHI RAIL | THALES GROUND TRANSPORTATION SYSTEMS (GTS) | FRANCE | Industrial Equipment |
Other operations with ATS CORPORATION
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 11/2023 | ATS CORPORATION | AVIDITY SCIENCE | UNITED STATES | Lab & Scientific Equipment |
REFERENCES
Valuation range: EV $300–700M
Revenue range: $100–200M
EBITDA range: $10–30M
EV/Revenue range: 1x - 3x
EV/EBITDA range: 15x - 25x
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SP INDUSTRIES by ATS CORPORATION are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: sp industries